Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Nilotinib recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Nilotinib (3 total). Check the affected lots below.

Most common reason: Failed specification (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Nilotinib. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Nilotinib recalls in 2026

2 initiated in 2026, 3 in total — newest first
Class III · Low risk

Nilotinib Capsules

Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.

Ongoing Failed specification Cipla USA, Inc. NDC 69097-032-74 D-0382-2026
Class III · Low risk

Nilotinib Capsules

Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.

Ongoing Failed specification Cipla USA, Inc. NDC 69097-031-74 D-0381-2026
Class II · Moderate risk

Nilotinib active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-817-2015